Association ID: association identifier in CanImmunother;
PMID: The identifier in PubMed;
Research type: The research type of the supporting publications, including clinical research, basic research, and case report;
Sample name: The name of sample;
Cancer sub-type: The name of cancer sub-type;
Cancer name ID: The ontology identifer of cancer sub-type in the Experimental Factor Ontology database;
Body part: The body part of cancer sub-type;
Target: Target name and its identifier in the UniprotKB database;
Immunotherapy: Immunotherapy name;
Control therapy: Control therapy name;
Immunotherapy type: The type of Immunotherapy;
Drugs: The name and identifier of immunotherapy and control therapy in the DrugBank or National Cancer Institute Thesaurus (NCIT) OBO Edition database;
Sample size of immunotherapy: The number of sample in the immunotherapy group;
Sample size of control therapy: The number of sample in the control therapy group;
Study design: The study design of the supporting publication;
Clinical significance: The clinical efficiency of immunotherapy compared with control therapy;
Adverse event: The adverse event of immunotherapy compared with control therapy;
Cell-based evidence: A evidence identifier and term in the Evidence & Conclusion Ontology for describing the experimental evidences on cell level;
Organism model based evidence: A evidence identifier and term in the Evidence & Conclusion Ontology for describing experimental evidences from animal model system ;
Biomarker: The biomarker name for immunotherapy;
Biomarker annotation: The biomarker and its identifier in UniprotKB and NCIT OBO Edition database;
Biomarker type: The type of biomarker;
Published year: The published year of the supporting publication;
Title: the title of the supporting publication;
Journal: The published journal of the supporting publication;
Abstract: The abstract of the supporting publication; |
